🇺🇸 hydrochlorothiazide, losartan in United States

1,936 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 1,936

Most-reported reactions

1. Fatigue — 261 reports (13.48%)
2. Diarrhoea — 254 reports (13.12%)
3. Nausea — 230 reports (11.88%)
4. Dyspnoea — 219 reports (11.31%)
5. Drug Ineffective — 212 reports (10.95%)
6. Off Label Use — 162 reports (8.37%)
7. Pain — 154 reports (7.95%)
8. Product Dose Omission Issue — 151 reports (7.8%)
9. Vomiting — 148 reports (7.64%)
10. Arthralgia — 145 reports (7.49%)

Source database →

Frequently asked questions

Is hydrochlorothiazide, losartan approved in United States?

hydrochlorothiazide, losartan does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for hydrochlorothiazide, losartan in United States?

University Hospital, Strasbourg, France is the originator. The local marketing authorisation holder may differ — check the official source linked above.